Northern Trust
IPSC icon

Northern Trust’s Century Therapeutics IPSC Stock Holding History

Northern Trust’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$522K Buy
230,820
+125,768
+120% +$264K ﹤0.01% 3605
2025
Q4 		$105K Buy
105,052
+38,052
+57% +$23.2K ﹤0.01% 4132
2025
Q3 		$33.4K Hold
67,000
– – ﹤0.01% 4331
2025
Q2 		$37.4K Sell
67,000
-222,601
-77% -$119K ﹤0.01% 4279
2025
Q1 		$138K Sell
289,601
-47,388
-14% -$35.6K ﹤0.01% 4041
2024
Q4 		$340K Sell
336,989
-15,523
-4% -$21.1K ﹤0.01% 3794
2024
Q3 		$603K Buy
352,512
+141,186
+67% +$277K ﹤0.01% 3529
2024
Q2 		$539K Buy
211,326
+26,711
+14% +$84.4K ﹤0.01% 3481
2024
Q1 		$772K Sell
184,615
-1,364
-0.7% -$5.77K ﹤0.01% 3411
2023
Q4 		$617K Sell
185,979
-1,215
-0.6% -$2.21K ﹤0.01% 3470
2023
Q3 		$374K Buy
187,194
+7,074
+4% +$18.8K ﹤0.01% 3595
2023
Q2 		$569K Buy
180,120
+17,447
+11% +$56.2K ﹤0.01% 3512
2023
Q1 		$564K Sell
162,673
-4,620
-3% -$20.3K ﹤0.01% 3416
2022
Q4 		$858K Buy
167,293
+3,778
+2% +$35.7K ﹤0.01% 3319
2022
Q3 		$1.62M Buy
163,515
+13,574
+9% +$143K ﹤0.01% 3123
2022
Q2 		$1.26M Buy
149,941
+15,457
+11% +$152K ﹤0.01% 3277
2022
Q1 		$1.69M Buy
134,484
+31,317
+30% +$415K ﹤0.01% 3178
2021
Q4 		$1.64M Sell
103,167
-621
-0.6% -$11.7K ﹤0.01% 3322
2021
Q3 		$2.61M Buy
+103,788
New +$2.81M ﹤0.01% 3136

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Northern Trust's IPSC Position: Q1 2026 in Review

Northern Trust increased its Century Therapeutics (IPSC) stake by 120% in Q1 2026, buying an estimated $264K and bringing the position to 230,820 shares worth $522K. The position accounts for ﹤0.01% of the portfolio, ranked #3605.

Northern Trust first reported a position in IPSC in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.61M in Q3 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Northern Trust held 230,820 shares of Century Therapeutics worth $522K as of Q1 2026.
  • Northern Trust bought 125,768 Century Therapeutics shares in Q1 2026, an estimated $264K.
  • Century Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3605 holding.
  • Northern Trust first reported a position in Century Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Northern Trust's Century Therapeutics position peaked at $2.61M in Q3 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.